No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

XELODA Generic Capecitabine

No Prescription » Prescription Drugs 17 » XELODA Generic Capecitabine

Capecitabine is used alone or with other treatments/medications to treat certain types of cancer (e.g. of the breast colon rectum). It works by slowing or stopping cancer cell growth and by decreasing tumor size.How to use Xeloda OralRead the Patient Information Leaflet provided by your pharmacist before you start taking capecitabine and each time you get a refill. If you have any questions regarding the information consult your doctor or pharmacist.Take this medication by mouth usually twice daily in the morning and evening or as directed by your doctor. It is best to take this with a full glass of water (8 ounces or 240 milliliters) within 30 minutes after the end of a meal. Capecitabine is usually taken every day for 2 weeks then stopped for 1 week. This course of treatment may be repeated as directed by your doctor.If you take any antacid products that contain aluminum or magnesium take capecitabine 2 hours before or after taking any antacids because these products may change the way your body absorbs capecitabine.The dosage is based on your medical condition body size and response to therapy. You may be taking a combination of different tablet sizes. Pay close attention to your dose and tablet sizes to avoid over- or under-dosing.Do not increase your dose or take this medication more often than directed without your doctor's approval. Your condition will not improve any faster and the risk of serious side effects may increase.Since this drug can be absorbed through the skin women who are pregnant or who may become pregnant should not handle this medication.Xeloda Oral is used to treat the following:Colon and Rectal Cancer that has Spread to Another Area Breast Cancer that has Spread to Another Part of the Body Lymph Node Positive Colon CancerXeloda Oral may also be used to treat:Stomach Cancer Cancer of the Pancreas

Buy XELODA Generic Capecitabine and other Prescription Drugs 17 products online at Medstore.

4436
Buy Online at Medstore - Click Here!

About XELODA Generic Capecitabine:

Product Type: Prescription Drugs 17

XELODA ( Generic Capecitabine )

XELODA (Generic Capecitabine)

Generic Capecitabine

500MG 120 Tablets Generic Capecitabine XELODA

View more Prescription Drugs 17

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.